174356-08-2 Usage
Type of compound
Heterocyclic organic compound
Structure
Fused five-membered ring containing two nitrogen atoms
Usage
Intermediate for the synthesis of various drugs and pesticides in pharmaceutical and agrochemical industries
Unique value
Valuable building block for the development of new chemical compounds with potential biological and therapeutic activities
Additional applications
Ligand in coordination chemistry, reagent in organic synthesis, and research and industrial fields.
Check Digit Verification of cas no
The CAS Registry Mumber 174356-08-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,4,3,5 and 6 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 174356-08:
(8*1)+(7*7)+(6*4)+(5*3)+(4*5)+(3*6)+(2*0)+(1*8)=142
142 % 10 = 2
So 174356-08-2 is a valid CAS Registry Number.
174356-08-2Relevant articles and documents
COMPOUNDS FOR TREATMENT OF CANCER
-
Paragraph 00223; 00246, (2014/09/29)
The present invention relates to pharmaceutical compositions for treating cancer comprising BRAF inhibitors, (e.g. vemurafenib) and/or MEK inhibitor, (e.g. trametinib, RO5068760), in combination with anti-tubulin compounds of the invention or other known tubulin inhibitors, and using such compositions for treating cancer such as melanoma, drug-resistant cancer, and cancer metastasis.
